Laboratory Evaluation of Von Willebrand Disease: Phenotypic Analysis

EJ Favaloro, S Mohammed, J McDonald, None, Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay. Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 2842- 2844 ,(2010) , 10.1111/J.1538-7836.2010.04123.X

E. J. FAVALORO, Diagnosis of type 1 vs. 2A and 2M von Willebrand disease. Haemophilia. ,vol. 18, ,(2012) , 10.1111/J.1365-2516.2011.02628.X

E. J. FAVALORO, J. KOUTTS, 2B or not 2B? Masquerading as von Willebrand disease? Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 317- 319 ,(2012) , 10.1111/J.1538-7836.2011.04585.X

A. HILLARP, M. STADLER, C. HADERER, J. WEINBERGER, C. M. KESSLER, J. RÖMISCH, Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 2216- 2223 ,(2010) , 10.1111/J.1538-7836.2010.04029.X

Zaverio M Ruggeri, Ileana Forza, Maria T Canciani, Pier Mannuccio Mannucci, Patrizia Marchese, Augusto B Federici, Jerry Ware, A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica. ,vol. 89, pp. 77- 85 ,(2004) , 10.3324/%X

D. KEELING, J. BEAVIS, R. MARR, K. SUKHU, P. BIGNELL, A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain. Haemophilia. ,vol. 18, ,(2012) , 10.1111/J.1365-2516.2011.02676.X

Emmanuel Favaloro, Roslyn Bonar, Geoff Kershaw, John Sioufi, Ross Baker, Mark Hertzberg, Alison Street, Katherine Marsden, Reducing Errors in Identification of von Willebrand Disease: The Experience of the Royal College of Pathologists of Australasia Quality Assurance Program Seminars in Thrombosis and Hemostasis. ,vol. 32, pp. 505- 513 ,(2006) , 10.1055/S-2006-947865

Emmanuel Favaloro, Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Seminars in Thrombosis and Hemostasis. ,vol. 34, pp. 113- 127 ,(2008) , 10.1055/S-2008-1066019

Emmanuel Favaloro, Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease Thrombosis and Haemostasis. ,vol. 104, pp. 1009- 1021 ,(2010) , 10.1160/TH10-06-0360

S. Giannini, A. M. Mezzasoma, M. Leone, P. Gresele, Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Haematologica. ,vol. 92, pp. 1647- 1654 ,(2007) , 10.3324/HAEMATOL.11313